Stratec SE

€25.00As of Sun 8 Nov 2026, 12:00 UTC
XETRA:SBSHealthcare
Country Germany
PE (Fwd) •••
TSR 10Y CAGR (5.64%)
Div yield 2.40%
ROE (0.17%)
Medical Devices
Beta (5Y) 0.84
PE TTM —
TSR TTM 10.06%
Mkt cap €303.9M
ROIC (0.34%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€28
11.62%
(52.62%)
Hold 12|0|5|9|11
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.29
0.32
0.36
0.39
12.87%
29.79%
48.57%
51.81%
Revenue€M
26.77
27.33
28.65
29.37
4.60%
1.52%
5.89%
8.27%
Peers (US$341.2M)
Cap (US$)
PE
969.6M
17.36x
104.5M
272.1x
342.4M
—
Capital
TTM
5Y
10Y
Leveragex
0.805
0.808
0.912
EBIT/Intx
0.850
0.484
0.521
Own earn%
(257.27)
(78.34)
(41.25)
Sh yield%
38.70
21.33
21.01
Owners
Insiders/Inst%
0.39
63.90
Short interest%
5.49
SBC / revenue%
1.80
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
20–25
$1 testx
—
Incr. ROIC%
3